Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Correlation of Glypican-4 Level with Basal Active Glucagon-Like Peptide 1 Level in Patients with Type 2 Diabetes Mellitus.

Lee SA, Koh G, Cho SJ, Yoo SY, Chin SO.

Endocrinol Metab (Seoul). 2016 Sep;31(3):439-445. doi: 10.3803/EnM.2016.31.3.439.

2.

Dietary carbohydrate intake, presence of obesity and the incident risk of type 2 diabetes in Japanese men.

Sakurai M, Nakamura K, Miura K, Takamura T, Yoshita K, Nagasawa SY, Morikawa Y, Ishizaki M, Kido T, Naruse Y, Nakashima M, Nogawa K, Suwazono Y, Sasaki S, Nakagawa H.

J Diabetes Investig. 2016 May;7(3):343-51. doi: 10.1111/jdi.12433. Epub 2015 Oct 31.

3.

Changing Clinical Characteristics according to Insulin Resistance and Insulin Secretion in Newly Diagnosed Type 2 Diabetic Patients in Korea.

Son JW, Park CY, Kim S, Lee HK, Lee YS; Insulin Resistance as Primary Pathogenesis in Newly Diagnosed, Drug Naïve Type 2 Diabetes Patients in Korea (SURPRISE) Study Group.

Diabetes Metab J. 2015 Oct;39(5):387-94. doi: 10.4093/dmj.2015.39.5.387. Epub 2015 Oct 22.

4.

Effects of 6-Month Sitagliptin Treatment on Insulin and Glucagon Responses in Korean Patients with Type 2 Diabetes Mellitus.

Yang HK, Kang B, Lee SH, Kim HS, Yoon KH, Cha BY, Cho JH.

Diabetes Metab J. 2015 Aug;39(4):335-41. doi: 10.4093/dmj.2015.39.4.335. Epub 2015 Jul 17.

5.

Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea.

Kim HS, Kim DM, Cha BS, Park TS, Kim KA, Kim DL, Chung CH, Park JH, Jang HC, Choi DS.

J Diabetes Investig. 2014 Nov;5(6):701-8. doi: 10.1111/jdi.12201. Epub 2014 Mar 16.

6.

A Prospective Study of Variability in Glycemic Control during Different Phases of the Menstrual Cycle in Type 2 Diabetic Women Using High Sensitivity C - Reactive Protein.

Gugapriya TS, Karthick S, Nagarjuna B.

J Clin Diagn Res. 2014 Apr;8(4):CC01-4. doi: 10.7860/JCDR/2014/8118.4240. Epub 2014 Apr 15.

7.

Insulin degludec compared with insulin glargine in insulin-naïve patients with type 2 diabetes: A 26-week, randomized, controlled, Pan-Asian, treat-to-target trial.

Onishi Y, Iwamoto Y, Yoo SJ, Clauson P, Tamer SC, Park S.

J Diabetes Investig. 2013 Nov 27;4(6):605-12. doi: 10.1111/jdi.12102. Epub 2013 Jun 3.

8.

Family history of diabetes, lifestyle factors, and the 7-year incident risk of type 2 diabetes mellitus in middle-aged Japanese men and women.

Sakurai M, Nakamura K, Miura K, Takamura T, Yoshita K, Sasaki S, Nagasawa SY, Morikawa Y, Ishizaki M, Kido T, Naruse Y, Suwazono Y, Nakagawa H.

J Diabetes Investig. 2013 May 6;4(3):261-8. doi: 10.1111/jdi.12033. Epub 2013 Feb 13.

9.

Challenges in achieving optimal glycemic control in type 2 diabetes patients with declining renal function: The Southeast Asia perspective.

Cc Chow F, Chan SP, Hwu CM, Suwanwalaikorn S, Wu AY, Gan SY, Zacarias MB.

J Diabetes Investig. 2012 Dec 20;3(6):481-9. doi: 10.1111/jdi.12006. Review.

10.

Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes.

Kashiwagi A, Kadowaki T, Tajima N, Nonaka K, Taniguchi T, Nishii M, Ferreira JC, Amatruda JM.

J Diabetes Investig. 2011 Oct 7;2(5):381-90. doi: 10.1111/j.2040-1124.2011.00120.x.

11.

Characterization of pancreatic islets in two selectively bred mouse lines with different susceptibilities to high-fat diet-induced glucose intolerance.

Nagao M, Asai A, Inaba W, Kawahara M, Shuto Y, Kobayashi S, Sanoyama D, Sugihara H, Yagihashi S, Oikawa S.

PLoS One. 2014 Jan 13;9(1):e84725. doi: 10.1371/journal.pone.0084725. eCollection 2014.

12.

Risk Factors for Type 2 Diabetes: Lessons Learned from Japanese Americans in Seattle.

Fujimoto WY, Boyko EJ, Hayashi T, Kahn SE, Leonetti DL, McNeely MJ, Shuman WP.

J Diabetes Investig. 2012 Jun 1;3(3):212-224. Epub 2012 Jan 27.

13.

Fasting insulin levels and metabolic risk factors in type 2 diabetic patients at the first visit in Japan: a 10-year, nationwide, observational study (JDDM 28).

Matsuba I, Saito K, Takai M, Hirao K, Sone H; Japan Diabetes Clinical Data Management Study Group.

Diabetes Care. 2012 Sep;35(9):1853-7. Epub 2012 Jun 4.

14.

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR; American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD).

Diabetes Care. 2012 Jun;35(6):1364-79. doi: 10.2337/dc12-0413. Epub 2012 Apr 19. Review. No abstract available. Erratum in: Diabetes Care. 2013 Feb;36(2):490.

15.

Insulin secretion based on the late oral glucose tolerance test period and incident diabetes: the San Antonio Heart Study.

Lorenzo C, Williams K, Haffner SM.

Diabet Med. 2012 Aug;29(8):e151-8. doi: 10.1111/j.1464-5491.2012.03660.x.

16.

Increased insulin resistance is associated with increased urinary excretion of chromium in non-diabetic, normotensive Saudi adults.

Bahijri SM, Alissa EM.

J Clin Biochem Nutr. 2011 Nov;49(3):164-8. doi: 10.3164/jcbn.10-148. Epub 2011 Jul 13.

17.

Predictors of impaired glucose regulation in patients with non-alcoholic fatty liver disease.

Hatziagelaki E, Karageorgopoulos DE, Chounta A, Tsiavou A, Falagas ME, Dimitriadis G.

Exp Diabetes Res. 2012;2012:351974. doi: 10.1155/2012/351974. Epub 2011 Sep 21.

18.
19.

Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss.

Purnell JQ, Kahn SE, Samuels MH, Brandon D, Loriaux DL, Brunzell JD.

Am J Physiol Endocrinol Metab. 2009 Feb;296(2):E351-7. doi: 10.1152/ajpendo.90769.2008. Epub 2008 Dec 2.

20.

Leptin levels in obese women with and without type 2 diabetes mellitus.

Buyukbese MA, Cetinkaya A, Kocabas R, Guven A, Tarakcioglu M.

Mediators Inflamm. 2004 Dec;13(5-6):321-5.

Supplemental Content

Support Center